8-K ·Filed Apr 20, 2026
8-K context-dependent: Items 7.01
Actionable Insight • Neutral
Monitor the next 10-Q for full financial results and cash usage trends, as this filing provides only a preliminary cash snapshot without operational context.
Final — all horizons settled through T+60d ⚠ clustered
NKTR ▼ -31.69% at T+60d
NEUTRAL call ✗ call lost -31.69% · α vs SPY -38.59% · entry $98.16 → $67.05
T+1d
-5.05%
call -5.05% · α -6.07%
$93.20
settled 6mo ago
T+5d
-14.62%
call -14.62% · α -15.70%
$83.81
settled 6mo ago
T+20d
-30.29%
call -30.29% · α -35.20%
$68.43
settled 5mo ago
T+60d
-31.69%
call -31.69% · α -38.59%
$67.05
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Nektar Therapeutics disclosed it had approximately $741.7 million in cash and marketable securities as of April 1, 2026. This is a routine liquidity update with no forward guidance or operational results provided.
Key Facts
- Nektar Therapeutics reported approximately $741.7 million in cash and marketable securities as of April 1, 2026
- The disclosure was made under Item 7.01 of Form 8-K for Regulation FD purposes
- The company emphasized that this is an estimate and not a comprehensive financial statement
Financial Impact
$741.7 million in cash and marketable securities
cash positionliquidity
Risk Factors
- High cash balance may indicate limited near-term dilution risk, but no information on burn rate or runway was provided
- Disclosure is unaudited and preliminary
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-164186 |
| Document: 0001193125-26-164186-index-headers.html | 0001193125-26-164186 |
| Document: 0001193125-26-164186-index.html | 0001193125-26-164186 |
| Document: 0001193125-26-164186.txt | 0001193125-26-164186 |
14 reports for NKTR
100% Hit rate best @ T+20▲ +28.57%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 9w ago | Press Release | $73.02 $68.50 | ▼ −6.19% | ▼ −4.20% | $35.78 (−51.00%) |
Aug 9, 2026 10w ago | Institutional Cluster | $74.86 $75.44 | ▲ +0.77% | ▲ +1.69% | $35.78 (−52.20%) |
Aug 7, 2026 10w ago | Court Ruling | $76.48 $74.19 | ▼ −2.99% | ▼ −2.60% | $35.78 (−53.22%) |
Jul 28, 2026 11w ago | Press Release | $70.68 $73.77 | ▲ +4.37% | ▼ −0.65% | $35.78 (−49.38%) |
Jun 11, 2026 18w ago | Institutional Cluster | $59.21 $72.92 | ▲ +23.15% | ▲ +21.26% | $35.78 (−39.57%) |
Jun 11, 2026 18w ago | Institutional Cluster | $59.21 $72.92 | ▲ +23.15% | ▲ +21.26% | $35.78 (−39.57%) |
May 21, 2026 21w ago | Insider Cluster | $66.61 $65.25 | ▲ +2.04% | ▲ +0.63% | $35.78 (+46.28%) |
May 8, 2026 23w ago | 8-K | $78.72 $56.23 | ▲ +28.57% | ▲ +28.27% | $35.78 (+54.55%) |
May 7, 2026 23w ago | 8-K | $81.89 $57.32 | ▼ −30.00% | ▼ −30.03% | $35.78 (−56.31%) |
Apr 24, 2026 25w ago | DEFA14A | $86.74 $65.56 | ▼ −24.42% | ▼ −29.37% | $35.78 (−58.75%) |
Showing 10 of 14
US Market Status
Market Closed — Opens in 30m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access